Literature DB >> 15175627

ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts.

L Mauvieux, C Helias, N Perrusson, B Lioure, N Sorel, F Brizard, M Lessard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15175627     DOI： 10.1038/sj.leu.2403403

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

1.  Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.

Authors:  Nuket Yurur Kutlay; Esra Pekpak; Sule Altıner; Talia Ileri; Arzu Nedime Vicdan; Handan Dinçaslan; Elif Unal Ince; Fatma Ajlan Tukun
Journal:  Int J Hematol       Date:  2016-07-08       Impact factor: 2.490

2.  Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Authors:  Michaela Dostalova Merkerova; Zdenek Krejcik; Hana Votavova; Monika Belickova; Alzbeta Vasikova; Jaroslav Cermak
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

3.  Amplification of c-MYC and MLL Genes as a Marker of Clonal Cell Progression in Patients with Myeloid Malignancy and Trisomy of Chromosomes 8 or 11.

Authors:  S Angelova; M Jordanova; B Spassov; V Shivarov; M Simeonova; I Christov; P Angelova; K Alexandrova; A Stoimenov; V Nikolova; I Dimova; P Ganeva; N Tzvetkov; E Hadjiev; S Toshkov
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

4.  A case of B-cell acute lymphoblastic leukemia in a child with Down syndrome bearing a t(2;12)(p12;p13) involving ETV6 and biallelic IGH@ rearrangements.

Authors:  Carlos A Tirado; David Shabsovich; Yeun Kim; Peter Traum; Sheeja Pullarkat; Michael Kallen; Nagesh Rao
Journal:  Biomark Res       Date:  2015-06-05

5.  Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.

Authors:  Agnieszka Dzikiewicz-Krawczyk; Anna Macieja; Ewa Mały; Danuta Januszkiewicz-Lewandowska; Maria Mosor; Marta Fichna; Ewa Strauss; Jerzy Nowak
Journal:  J Hematol Oncol       Date:  2014-06-02       Impact factor: 17.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.